Variants of the GRIK4 gene influence the effectiveness of citalopram, a selective serotonin reuptake inhibitor used to treat major depressive disorders, by potentially predicting individual responses and allowing for more tailored antidepressant therapy. While interactions with dexamethasone have been noted, these are not clearly understood in terms of pharmacokinetics and may relate to broader neuropharmacological effects or treatment responses in psychiatric settings.